InsiderDirector
James E Flynn / DEERFIELD MANAGEMENT COMPANY, L.P. / Deerfield Mgmt III, L.P. / Deerfield Mgmt HIF, L.P. / Deerfield Mgmt IV, L.P. / Mgmt L.P. Deerfield / Deerfield Private Design Fund III, L.P. / Deerfield Healthcare Innovations Fund, L.P. / Deerfield Pr Insider Trading Activity
Every SEC Form 4 transaction reported by James E Flynn / DEERFIELD MANAGEMENT COMPANY, L.P. / Deerfield Mgmt III, L.P. / Deerfield Mgmt HIF, L.P. / Deerfield Mgmt IV, L.P. / Mgmt L.P. Deerfield / Deerfield Private Design Fund III, L.P. / Deerfield Healthcare Innovations Fund, L.P. / Deerfield Pr, sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Is James E Flynn / DEERFIELD MANAGEMENT COMPANY, L.P. / Deerfield Mgmt III, L.P. / Deerfield Mgmt HIF, L.P. / Deerfield Mgmt IV, L.P. / Mgmt L.P. Deerfield / Deerfield Private Design Fund III, L.P. / Deerfield Healthcare Innovations Fund, L.P. / Deerfield Pr buying or selling?
James E Flynn / DEERFIELD MANAGEMENT COMPANY, L.P. / Deerfield Mgmt III, L.P. / Deerfield Mgmt HIF, L.P. / Deerfield Mgmt IV, L.P. / Mgmt L.P. Deerfield / Deerfield Private Design Fund III, L.P. / Deerfield Healthcare Innovations Fund, L.P. / Deerfield Pr reported 33 open-market buys ($449.4M) and 27 sells ($345.3M) across 60 Form 4 filings at 33 companies — a net buying position of $104.1M.
Source: SEC EDGAR Form 4
Key Statistics (as of Mar 3, 2026)
Total Form 4 filings
60
SEC EDGAR
Companies
33
Buys (33)
$449.4M
Sells (27)
$345.3M
Insider sentiment
Net buyingNet insider flow of $104.1M in net buying, filed between May 10, 2018 – Mar 3, 2026.
Companies James E Flynn / DEERFIELD MANAGEMENT COMPANY, L.P. / Deerfield Mgmt III, L.P. / Deerfield Mgmt HIF, L.P. / Deerfield Mgmt IV, L.P. / Mgmt L.P. Deerfield / Deerfield Private Design Fund III, L.P. / Deerfield Healthcare Innovations Fund, L.P. / Deerfield Pr files for
| # | Company | Form 4 filings |
|---|---|---|
| 1 | ONCROncorus, Inc. | 6 |
| 2 | LRMRLarimar Therapeutics, Inc. | 5 |
| 3 | QTTBHomology Medicines, Inc. | 5 |
| 4 | XERSXERIS PHARMACEUTICALS INC | 5 |
| 5 | ACRSAclaris Therapeutics, Inc. | 4 |
| 6 | MIRMMirum Pharmaceuticals, Inc. | 4 |
| 7 | NUVLNuvalent, Inc. | 3 |
| 8 | AFIBAcutus Medical, Inc. | 2 |
| 9 | SPRYARS Pharmaceuticals, Inc. | 2 |
| 10 | AHCOAdaptHealth Corp. | 1 |
Recent James E Flynn / DEERFIELD MANAGEMENT COMPANY, L.P. / Deerfield Mgmt III, L.P. / Deerfield Mgmt HIF, L.P. / Deerfield Mgmt IV, L.P. / Mgmt L.P. Deerfield / Deerfield Private Design Fund III, L.P. / Deerfield Healthcare Innovations Fund, L.P. / Deerfield Pr transactions
| Date | Ticker | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Mar 3, 2026 | LRMR | Director, 10% Owner | Purchase | 5.0M | $25.0M |
| Nov 25, 2025 | NUVL | Director, 10% Owner | Sale | 742.6K | $70.9M |
| Aug 4, 2025 | LRMR | Director, 10% Owner | Purchase | 9.4M | $30.0M |
| Jul 1, 2025 | SPRY | 10% Owner | Sale | 740.1K | $13.7M |
| Nov 14, 2024 | SPRY | 10% Owner | Sale | 563.3K | $10.1M |
| Oct 24, 2024 | NUVL | Director, 10% Owner | Sale | 2.0M | $195.5M |
| Sep 17, 2024 | BCAX | Other, 10% Owner | Purchase | 70.0K | $1.3M |
| Mar 12, 2024 | AHCO | Other, 10% Owner | Sale | 350.0K | $3.8M |
| Feb 16, 2024 | LRMR | Director, 10% Owner | Purchase | 4.3M | $37.5M |
| Dec 31, 2022 | ONCR | Other, 10% Owner | Sale | 336.2K | $88.3K |
| Dec 27, 2022 | ONCR | Other, 10% Owner | Sale | 73.4K | $19.9K |
| Dec 22, 2022 | ONCR | Other, 10% Owner | Sale | 128.3K | $37.6K |
| Dec 15, 2022 | ONCR | Other, 10% Owner | Sale | 13.8K | $5.3K |
| Nov 7, 2022 | NUVL | Director, 10% Owner | Purchase | 650.0K | $21.8M |
| Sep 21, 2022 | LRMR | Director, 10% Owner | Purchase | 11.1M | $35.0M |
| Jun 8, 2022 | MIRM | Other, 10% Owner | Sale | 38.5K | $962.3K |
| May 10, 2022 | PEPG | Other, 10% Owner | Purchase | 416.7K | $5.0M |
| Oct 28, 2021 | XLO | Other, 10% Owner | Purchase | 775.0K | $12.4M |
| Jul 21, 2021 | AFIB | Director, 10% Owner | Purchase | 1.1M | $15.0M |
| Jul 13, 2021 | MIRM | Other, 10% Owner | Sale | 99.3K | $1.6M |
| Jul 7, 2021 | MIRM | Other, 10% Owner | Sale | 66.7K | $1.1M |
| Jul 2, 2021 | LRMR | Director, 10% Owner | Purchase | 685.7K | $6.0M |
| Jun 3, 2021 | OMIC | Other, 10% Owner | Purchase | 1.5M | $33.0M |
| May 4, 2021 | HOWL | Other, 10% Owner | Purchase | 800.0K | $12.8M |
| Mar 30, 2021 | EWTX | Other, 10% Owner | Purchase | 625.0K | $10.0M |
Showing the 25 most recent filings of 60. Screen every filing.
James E Flynn / DEERFIELD MANAGEMENT COMPANY, L.P. / Deerfield Mgmt III, L.P. / Deerfield Mgmt HIF, L.P. / Deerfield Mgmt IV, L.P. / Mgmt L.P. Deerfield / Deerfield Private Design Fund III, L.P. / Deerfield Healthcare Innovations Fund, L.P. / Deerfield Pr insider trading FAQ
Is James E Flynn / DEERFIELD MANAGEMENT COMPANY, L.P. / Deerfield Mgmt III, L.P. / Deerfield Mgmt HIF, L.P. / Deerfield Mgmt IV, L.P. / Mgmt L.P. Deerfield / Deerfield Private Design Fund III, L.P. / Deerfield Healthcare Innovations Fund, L.P. / Deerfield Pr buying or selling?
Across 60 SEC Form 4 filings, James E Flynn / DEERFIELD MANAGEMENT COMPANY, L.P. / Deerfield Mgmt III, L.P. / Deerfield Mgmt HIF, L.P. / Deerfield Mgmt IV, L.P. / Mgmt L.P. Deerfield / Deerfield Private Design Fund III, L.P. / Deerfield Healthcare Innovations Fund, L.P. / Deerfield Pr reported 33 open-market purchases totaling $449.4M and 27 sales totaling $345.3M — a net buying position of $104.1M.
Which companies does James E Flynn / DEERFIELD MANAGEMENT COMPANY, L.P. / Deerfield Mgmt III, L.P. / Deerfield Mgmt HIF, L.P. / Deerfield Mgmt IV, L.P. / Mgmt L.P. Deerfield / Deerfield Private Design Fund III, L.P. / Deerfield Healthcare Innovations Fund, L.P. / Deerfield Pr file Form 4s for?
James E Flynn / DEERFIELD MANAGEMENT COMPANY, L.P. / Deerfield Mgmt III, L.P. / Deerfield Mgmt HIF, L.P. / Deerfield Mgmt IV, L.P. / Mgmt L.P. Deerfield / Deerfield Private Design Fund III, L.P. / Deerfield Healthcare Innovations Fund, L.P. / Deerfield Pr has reported insider transactions at 33 companies, most often Oncorus, Inc. (ONCR), Larimar Therapeutics, Inc. (LRMR), Homology Medicines, Inc. (QTTB), XERIS PHARMACEUTICALS INC (XERS), Aclaris Therapeutics, Inc. (ACRS).
How far back does James E Flynn / DEERFIELD MANAGEMENT COMPANY, L.P. / Deerfield Mgmt III, L.P. / Deerfield Mgmt HIF, L.P. / Deerfield Mgmt IV, L.P. / Mgmt L.P. Deerfield / Deerfield Private Design Fund III, L.P. / Deerfield Healthcare Innovations Fund, L.P. / Deerfield Pr's filing history go?
Trabud holds James E Flynn / DEERFIELD MANAGEMENT COMPANY, L.P. / Deerfield Mgmt III, L.P. / Deerfield Mgmt HIF, L.P. / Deerfield Mgmt IV, L.P. / Mgmt L.P. Deerfield / Deerfield Private Design Fund III, L.P. / Deerfield Healthcare Innovations Fund, L.P. / Deerfield Pr's SEC Form 4 filings from May 10, 2018 – Mar 3, 2026, sourced directly from SEC EDGAR.
Where does Trabud get James E Flynn / DEERFIELD MANAGEMENT COMPANY, L.P. / Deerfield Mgmt III, L.P. / Deerfield Mgmt HIF, L.P. / Deerfield Mgmt IV, L.P. / Mgmt L.P. Deerfield / Deerfield Private Design Fund III, L.P. / Deerfield Healthcare Innovations Fund, L.P. / Deerfield Pr's insider trading data?
Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.
Related Content
Track James E Flynn / DEERFIELD MANAGEMENT COMPANY, L.P. / Deerfield Mgmt III, L.P. / Deerfield Mgmt HIF, L.P. / Deerfield Mgmt IV, L.P. / Mgmt L.P. Deerfield / Deerfield Private Design Fund III, L.P. / Deerfield Healthcare Innovations Fund, L.P. / Deerfield Pr and every other insider
Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.
Open the screener